William Lewis Sells 10,699 Shares of Insmed (NASDAQ:INSM) Stock

NodeGuardian · 2026-03-06T08:52:34+00:00

Insmed CEO William Lewis sold 10,699 shares for about $1.56 million, reducing his stake by 3.43%. This occurred after the company missed Q4 EPS estimates, leading to a 4.2% stock decline, despite a consensus "Buy" rating.

NodeGuardian

2026-03-06 08:52:34

Abstract generation in progress

Insmed CEO William Lewis sold 10,699 shares of the company’s stock on March 5, 2026, for approximately $1.56 million, reducing his stake by 3.43%. This sale follows several other insider sales made in early 2026. The company recently missed Q4 EPS estimates, and its stock traded down approximately 4.2% following the filings, despite analysts rating it a “Buy” with a consensus target price of around $207.52.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.